Pseudoephedrine
Sympathomimetics
Sold as GALPSEUD LINCTUS · NON-DROWSY SINUTAB · PANADOL COLD & SINUS · CONTAC NON DROWSY 12 HOUR…
- Drug class
- Sympathomimetics
- Availability
- Over-the-counter
- Routes
- Oral
- Markets covered
- 2
- Products on record
- 27
Overview
Plain-language summary, compiled from the cited regulatory records
Pseudoephedrine is a sympathomimetic medication [1]. It is used to temporarily relieve nasal congestion associated with the common cold, hay fever, or other upper respiratory allergies [1]. It also provides temporary relief from sinus congestion and pressure [1].
This active ingredient belongs to the drug class of sympathomimetics, specifically categorized under R01BA [1]. Pseudoephedrine is available in various over-the-counter products.
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 22 | May 29, 2026 |
| US United States | FDA | 5 | February 3, 2026 |
GBUnited Kingdom· MHRA
22 products
Uses
Pseudoephedrine 60mg Tablets are indicated for symptomatic relief of congestion of the mucous membranes in the upper respiratory tract. Pseudoephedrine is particularly useful as a decongestant in the nasal mucosa and sinuses, and as such is indicated in allergic rhinitis, vasomotor rhinitis, the common cold and influenza.
How to take
USUnited States· FDA
5 products
Uses
Uses temporarily relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies temporarily relieves sinus congestion and pressure
How to take
Drug interactions
Known interactions involving Pseudoephedrine. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL556120015 · revised May 29, 2026
- [2]FDA DailyMed · 0a2672f0-4e6f-48… · revised January 29, 2026 [PDF]
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.